FDA Compliance Health Check: Auditing Your LTO, CPN, and CPR Before They Expire

Why an FDA Authorization Audit Matters

If your business manufactures, imports, distributes, or sells food, drugs, cosmetics, or household/urban hazardous substances (HUHS) in the Philippines, it depends on authorizations from the Food and Drug Administration (FDA). The establishment holds a License to Operate (LTO). The products carry their own authorizations, such as a Certificate of Product Registration (CPR) or a Certificate of Product Notification (CPN).

Each authorization has its own expiry date, and none renews itself. The FDA's rules also changed during 2025, including how and when LTO renewals may be filed. A periodic audit lets you find gaps while there is still time to fix them, rather than after something has lapsed.

This article is for owners, compliance officers, and regulatory personnel of FDA-regulated establishments, including foreign-owned companies with Philippine operations. It reflects FDA issuances available as of September 2026.

Establishment-Level vs. Product-Level Authorizations

Republic Act No. 9711, the Food and Drug Administration Act of 2009, treats licensing and registration as separate processes. Licensing is the approval of an application to operate or establish an establishment before engaging in the manufacture, importation, exportation, sale, distribution, and related activities involving health products, while registration is the approval of an application to register health products before those same activities.

In practice, this produces three authorizations that businesses often mix up:

Which product category requires which authorization depends on the FDA's classification of your product. Other products, such as medical devices, are subject to their own FDA authorizations and procedures. Confirm the correct pathway for each product line rather than assuming one framework covers everything.

The Current LTO Framework: Administrative Order No. 2024-0015

LTO applications are now governed by Department of Health Administrative Order (AO) No. 2024-0015, which repealed AO No. 2020-0017. The FDA announced that the order took effect on 12 January 2025, with a pilot run of eServices Portal filings for drug distributors, drug traders, and pharmaceutical outlets starting 20 January 2025. Existing and pending applications for other health product establishments received before the implementation date were to be processed under AO No. 2020-0017 until exhausted, with separate FDA issuances to follow.

The order also introduced a pre-assessment fee. The FDA stated that this fee applies to LTO applications lodged through the eServices Portal by drug distributors (importers, exporters, and wholesalers), drug traders, pharmaceutical outlets, and contract research organizations and sponsors. Businesses in other categories should confirm with the FDA whether and when the fee applies to them.

The LTO Renewal Filing Window: What Changed in 2025

The timing of LTO renewal filing changed twice within about a year. This is where outdated assumptions cause the most trouble.

Under Advisory No. 2025-0095, the FDA began accepting LTO renewal applications up to 180 days before expiry, instead of 90 days, starting 17 February 2025, as an interim measure effective until further notice. The FDA later issued Advisory No. 2025-0095-A, which lifts the advisory on that interim extension. With the interim measure lifted, the 90-day period that Advisory 2025-0095 treated as the baseline governs again.

Two cautions apply. First, check the text of Advisory No. 2025-0095-A on the FDA website for its exact effective date and any transitional details before relying on this summary. Second, the FDA issues advisories frequently, so confirm that no newer issuance has changed the window again. Filing outside the applicable window risks rejection or delay.

Advisory No. 2025-0095 also said that paying the correct fee before the LTO expires would not result in surcharges even if the payment posted later. That provision was part of an advisory that has since been lifted. Do not assume it still applies, and confirm the current treatment of surcharges with the FDA.

Digital Filing and Sector-Specific Transitions

The FDA has been moving establishment types onto its eServices Portal in phases, and transition arrangements differ by sector. Household/Urban Hazardous Substances (HUHS) establishments are a clear example.

Beginning 2 June 2025, all HUHS LTO initial, renewal, and variation applications were to be filed exclusively through the FDA eServices Portal System. The FDA also set time-limited transition measures for HUHS establishments. These included automatic renewal with waived surcharges for eligible establishments that submitted a letter of intent by 30 May 2025, and a warning that renewal filed past the extended validity period would be charged the applicable fees and surcharges. Previously issued HUHS CPRs were likewise eligible for an extended validity until 30 June 2025 under an interim procedure.

For most businesses, these HUHS dates have passed. The lesson still applies: transitional relief is time-bound, and businesses that did not act inside the stated window may face regular fees and surcharges. Confirm the current filing channel and any transition status for your own establishment type.

Documentary requirements change as well. For example, FDA Advisory No. 2025-1397 addresses the removal of product samples as a requirement in registration applications for food and dietary supplements. Check the latest advisory for your product category before assembling a renewal or registration file.

Validity, Fees, and Penalties: Rely on Your Own Documents

The validity period of an LTO, CPR, or CPN is stated on the authorization itself and depends on the governing issuance, the type of authorization, and the category of the establishment or product. Renewal fees, pre-assessment fees, and surcharges are likewise set by FDA issuances and fee schedules that vary by category.

This article therefore does not state general validity terms, fee amounts, or surcharge rates. The full text of AO No. 2024-0015 and its annexes on the FDA website should be consulted, together with the FDA's current fee schedule and the specific advisory covering your product category. Use the expiry date printed on each of your own authorizations as the starting point of your renewal calendar.

What an FDA Compliance Health Check Should Cover

1. Authorization Inventory

• List every LTO, CPR, and CPN your business holds, with expiry dates and the responsible person for each.

• Confirm that every product you make, import, or sell is covered by the right authorization. Variants, dosage forms, and presentations may each require their own.

2. Renewal Calendar

• Work back from each expiry date using the currently applicable filing window.

• Include time to gather documents, pay fees, and respond to FDA requests.

3. Business Information

• Compare your FDA records against your current SEC or DTI registration, address, ownership, and authorized representatives.

• Confirm that any required qualified personnel, and their credentials, are current.

4. Product Accuracy

• Check that each product still matches its registered or notified version, including formulation, labeling, and packaging.

• Identify changes that may need to be reported to the FDA before renewal.

5. Filing Readiness

• Confirm the correct eServices Portal channel and the official email address on file.

• Confirm the current documentary requirements for your category, since these change through advisories.

Common Mistakes

• Watching only the LTO. Each product authorization has its own expiry date.

• Planning around a temporary advisory. The 180-day window was an interim measure, and it has been lifted.

• Assuming a transition period still applies. Sector-specific relief, such as the HUHS measures, was limited to stated dates.

• Letting business or product details drift. Records that no longer match your actual operations can complicate renewals.

• Relying on an outdated checklist. Requirements for a category may change after your last filing.

Practical Compliance Checklist

• Compile a master list of all LTO, CPR, and CPN expiry dates

• Confirm the currently applicable renewal filing window on the FDA website

• Read Advisory No. 2025-0095-A for its exact effective date and terms

• Verify the current fee schedule and surcharge treatment for your category

• Check that FDA-registered business details match your SEC/DTI documents

• Check each product against its registered or notified details

• Confirm the eServices Portal channel and official email address for your establishment type

• Review the latest FDA advisories on documentary requirements for your product category

• Assign an owner and set internal reminders well ahead of each filing window

What Businesses Should Do Next

Start with the expiry dates printed on your own authorizations, then confirm the filing window and documentary requirements for each one directly on the FDA website. Do this well ahead of expiry, because FDA rules and advisories have changed often in recent years.

Businesses that would like help organizing an FDA compliance calendar, reconciling product-level authorizations, or preparing renewal and variation filings may consider working with a professional business consulting team to manage the process and confirm current requirements with the FDA.